The Global Multiple Sclerosis Drugs Market size is expected to grow from USD 28.83 billion in 2022 to USD 41.95 billion by 2030, at a CAGR of 4.8% during the forecast period (2023-2030).
Multiple sclerosis (MS) is a chronic neurological condition caused by an unknown inflammatory process in the central nervous system (CNS). It leads to multifocal demyelination and axonal damage, primarily...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek